Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sudarshan K Vijay"'
Autor:
Mukesh Tiwari, Ashish Jha, Bhuwan Chandra Tiwari, Sudarshan K Vijay, Naveen Jamwal, Amresh Kumar Singh
Publikováno v:
Heart India, Vol 10, Iss 1, Pp 30-37 (2022)
Context: Patients with symptomatic complex coronary artery disease (CAD) who could not undergo bypass surgery for any reason often continue to have symptoms and impaired quality of life (QoL) on optimal medical therapy (OMT) Aims: This study aimed to
Externí odkaz:
https://doaj.org/article/21edfa27e4924e65bb48590743c51f62
Autor:
Anjum Naim, Ashish Jha, Amresh Kumar Singh, Bhuwan Chandra Tiwari, Sudarshan K Vijay, Naveen Jamwal
Publikováno v:
Heart India, Vol 10, Iss 2, Pp 74-79 (2022)
Context: Elevated uric acid (UA) is seen in several vascular diseases. Its significance as a prognostic marker in patients undergoing percutaneous coronary intervention (PCI) is unknown. Aims: The aim of this study was to evaluate the association bet
Externí odkaz:
https://doaj.org/article/94fad4b77ad441f683696a4a281a8e6e
Autor:
Sujith Kumar Pulukool, Sai Krishna Srimadh Bhagavatham, Sudarshan K. Vijay, Abdulrahman I. Almansour, Sandeep Chaudhary, Farah Abuyousef, Na’il Saleh, Pratima Tripathi
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background:The most frequent lesion in the blood vessels feeding the myocardium is vascular stenosis, a condition that develops slowly but can prove to be deadly in a long run. Non-invasive biomarkers could play a significant role in timely diagnosis
Externí odkaz:
https://doaj.org/article/330edbf8a26546d795807f4971a4058a
Publikováno v:
Acta Diabetologica. 46:27-33
The purpose of this study was to assess the effects of PPAR-gamma agonists (pioglitazone and rosiglitazone) on mediators of endothelial dysfunction and markers of angiogenesis in patients with type-2 diabetes. Pioglitazone group showed favorable redu